Combination therapies comprising antibody molecules to lag-3

作者: Walter A. Blattler , Hwai Wen Chang , Jennifer Marie Mataraza , Glenn Dranoff , Chrystlle Brignone

DOI:

关键词:

摘要: Combination therapies comprising antibody molecules that specifically bind to LAG-3 are disclosed. The combination can be used treat, prevent and/or diagnose cancerous or infectious disorders.

参考文章(281)
David M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, Multivalent Immunoglobulin-Based Bioactive Assemblies ,(2006)
M. Josefina Coloma, Sherie L. Morrison, Genetically engineered bispecific tetravalent antibodies ,(1994)
Paul A. Moore, Deryk T. Loo, Francine Zhifen Chen, Ling Huang, Leslie S. Johnson, Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof ,(2011)
Francois Gessier, Joanna Hergovich Lisztwan, Nicole Buschmann, Philipp Holzer, Pascal Furet, Joerg Kallen, Keiichi Masuya, Edgar Jacoby, Haixia Ren, Joerg Berghausen, Carole Pissot Soldermann, Stefan Stutz, Substituted isoquinolinones and quinazolinones ,(2010)
Christian Klein, Wolfgang Schaefer, Bivalent, bispecific antibodies ,(2008)
Jochen G. Salfeld, Richard W. Dixon, Tariq Ghayur, Chengbin Wu, Dual variable domain immunoglobulins and uses thereof ,(2006)
Kirston Koths, Gregory Harrowe, Deborah Lee Zimmerman, Li Long, Cheng Liu, W. Michael Kavanaugh, Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis ,(2003)
George Heavner, Pseudo-antibody constructs ,(2002)
Johan Grooten, Nico Mertens, Novel heterodimeric fusion proteins ,(2001)
Philip Tan, John W. Blankenship, Polypeptide heterodimers and uses thereof ,(2010)